P
polish1023
Hello,
We are developing an active implant (pre-CE). As we are planning to conduct preclinical studies, the implants we have available at this point have been created by a different manufacturing mold than the one we plan to use to make the implants that are dedicated to humans.
We believe that the change in mold will not affect the safety and performance of the implant and therefore we would like to continue with our preclinical plan and implant the current implant configuration (it will most probably take at least 3 months to manufacture the new mold).
If we plan to submit the preclinical data along with a rationale and bench tests on why these implants are equivalent in terms of safety and efficacy, do you anticipate any problems with the EC or Competent Authorities?

We are developing an active implant (pre-CE). As we are planning to conduct preclinical studies, the implants we have available at this point have been created by a different manufacturing mold than the one we plan to use to make the implants that are dedicated to humans.
We believe that the change in mold will not affect the safety and performance of the implant and therefore we would like to continue with our preclinical plan and implant the current implant configuration (it will most probably take at least 3 months to manufacture the new mold).
If we plan to submit the preclinical data along with a rationale and bench tests on why these implants are equivalent in terms of safety and efficacy, do you anticipate any problems with the EC or Competent Authorities?
